Loading data
DCBONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of revenue | 47.85 m USD | 41.3 m USD | 34.5 m USD | 28.18 m USD | 20.79 m USD |
| Gross profit | 194.84 m USD | 175.64 m USD | 146.34 m USD | 114.73 m USD | 83.46 m USD |
| Research and development expense | 50.12 m USD | 43.91 m USD | 35.48 m USD | 24.78 m USD | 20.36 m USD |
| Operating profit | 23.24 m USD | 21.29 m USD | -3.71 m USD | 4.19 m USD | -13.45 m USD |
| Profit before tax | 24.45 m USD | 23.71 m USD | 4.85 m USD | 7.78 m USD | -13.43 m USD |
| Income tax expense | -13.07 m USD | -3.02 m USD | 2.01 m USD | 764 k USD | 172 k USD |
| Net income (reported basis) | 37.51 m USD | 26.74 m USD | 2.84 m USD | 7.02 m USD | -13.6 m USD |
| Basic earnings per share | 1.31 USD/share | 0.88 USD/share | 0.09 USD/share | 0.21 USD/share | -0.41 USD/share |
| Diluted earnings per share | 1.28 USD/share | 0.86 USD/share | 0.08 USD/share | 0.21 USD/share | -0.41 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.